415 related articles for article (PubMed ID: 32928134)
1. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.
Danjuma MI; Almasri H; Alshokri S; Khir FK; Elmalik A; Battikh NG; Abdallah IMH; Elshafei M; Fatima H; Mohamed MFH; Maghoub Y; Hussain T; Kamal I; Anwer Z; Bidmos MA; Elzouki AN
BMC Geriatr; 2020 Sep; 20(1):346. PubMed ID: 32928134
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools.
Danjuma MI; Shokri SA; Abubeker IY; Malik AE; Abdallah IMH; Shafei MNE; Fatima H; Mahmoud M; Hussain T; Maghoub Y; Sajid J; Zouki ANE
Medicine (Baltimore); 2020 Jan; 99(1):e18569. PubMed ID: 31895800
[TBL] [Abstract][Full Text] [Related]
3. The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome.
Naseralallah LM; Aboujabal BA; Geryo NM; Al Boinin A; Al Hattab F; Akbar R; Umer W; Abdul Jabbar L; Danjuma MI
PLoS One; 2022; 17(9):e0268705. PubMed ID: 36048762
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Danjuma MI; Naseralallah LMA; AbouJabal B; Mohamed MF; Abubeker IY; Jabbar LA; Elzouki A
Sci Rep; 2021 Sep; 11(1):17887. PubMed ID: 34504198
[TBL] [Abstract][Full Text] [Related]
5. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.
Das S; Behera SK; Xavier AS; Velupula S; Dkhar SA; Selvarajan S
Clin Drug Investig; 2018 Mar; 38(3):211-218. PubMed ID: 29185238
[TBL] [Abstract][Full Text] [Related]
6. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
7. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
Teschke R; Danan G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
[TBL] [Abstract][Full Text] [Related]
8. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study.
Rodríguez A; García-García I; Martínez de Soto L; Gómez López De Las Huertas A; Borobia AM; González-Torbay A; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
Front Pharmacol; 2022; 13():819589. PubMed ID: 35370653
[No Abstract] [Full Text] [Related]
9. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
Teschke R; Méndez-Sánchez N; Eickhoff A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
[TBL] [Abstract][Full Text] [Related]
10. Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool.
Bracken LE; Nunn AJ; Kirkham JJ; Peak M; Arnott J; Smyth RL; Pirmohamed M; Turner MA
PLoS One; 2017; 12(1):e0169393. PubMed ID: 28046035
[TBL] [Abstract][Full Text] [Related]
11. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.
Scalfaro E; Streefkerk HJ; Merz M; Meier C; Lewis D
Drug Saf; 2017 Aug; 40(8):715-727. PubMed ID: 28508325
[TBL] [Abstract][Full Text] [Related]
12. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
Danan G; Teschke R
Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
[TBL] [Abstract][Full Text] [Related]
13. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.
Rockey DC; Seeff LB; Rochon J; Freston J; Chalasani N; Bonacini M; Fontana RJ; Hayashi PH;
Hepatology; 2010 Jun; 51(6):2117-26. PubMed ID: 20512999
[TBL] [Abstract][Full Text] [Related]
14. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
Teschke R; Schulze J; Eickhoff A; Danan G
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
[TBL] [Abstract][Full Text] [Related]
15. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
16. Causality assessment for suspected DILI during clinical phases of drug development.
Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
[TBL] [Abstract][Full Text] [Related]
17. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019.
Teschke R
Front Pharmacol; 2019; 10():730. PubMed ID: 31396080
[TBL] [Abstract][Full Text] [Related]
18. Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury.
Ghabril M; Gu J; Yoder L; Corbito L; Dakhoul L; Ringel A; Beyer CD; Vuppalanchi R; Barnhart H; Hayashi PH; Chalasani N
Clin Transl Gastroenterol; 2020 Apr; 11(4):e00141. PubMed ID: 32251016
[TBL] [Abstract][Full Text] [Related]
19. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).
Teschke R; Danan G
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33800917
[TBL] [Abstract][Full Text] [Related]
20. Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.
Teschke R; Eickhoff A; Schulze J; Danan G
Transl Gastroenterol Hepatol; 2021; 6():51. PubMed ID: 34423172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
